275
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Quantitative structure-activity relationship study of human A3 adenosine receptor antagonists: Derivatives of 2-aryl-1,2,4-triazolo[4,3-α]quinoxaline

&
Pages 165-169 | Received 23 Jun 2006, Accepted 11 Sep 2006, Published online: 04 Oct 2008

References

  • Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. Pharmacol Rev 2001; 53: 527–552
  • Jacobson KA, Knutsen LJS. Handbook of experimental pharmacology. Springer, Berlin 2001; 129–175
  • Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fink JS, Reppert SM. Mol Pharmacol 1993; 44: 524–532
  • Gao Z-G, Blaustein JB, Gross AS, Melman N, Jacobson KA. Biochem Pharmacol 2003; 65: 1675–1684
  • Jacobson KA, Suzuki F. Drug Dev Res 1996; 39: 289–300
  • Abbracchio MP, Brambilla R, Kim HO, von Lubitz DKJE, Jacobson KA, Cattabeni FG. Mol Pharmacol 1995; 48: 1033–1045
  • Ali H, Choi OH, Fraundorfer PF, Yamada K, Gonzaga HMS, Beaven MA. J Pharmacol Exp Ther 1996; 276: 837–845
  • (a) van Schaick EA, Jacobson KA, Kim HO, Ijzerman AP, Danhof M. Eur J Pharmacol 1996; 308: 311–314, (b) Meade CJ, Mierau J, Leon I, Ensinger HA. J Pharmacol Exp Ther 1996;279:1148–1156
  • (b) Forsythe P, Ennis M. Inflammation Res 1999, 48: 301–307, (b) Marx D, Ezeamuzie CI, Nieber K, Szelenyi I. Drug News Perspect 2001;14:89–100
  • Brambilla R, Cattabeni F, Ceruti S, Barbieri D, Franceschi C, Kim Y-C, Jacobson KA, Klotz K-N, Lohse MJ, Abbracchio MP. Naunyn-Schmiedeberg's Arch Pharmacol 2000; 361: 225–234
  • von Lubitz DKJE, Lin RCS, Popik P, Carter MF, Jacobson KA. Eur J Pharmacol 1994; 263: 59–67
  • Colotta V, Catarzi D, Varano F, Calabri FR, Lenzi O, Filacchioni G, Martini C, Trincavelli L, Deflorian F, Moro S. J Med Chem 2004; 47: 3580–3590
  • Hansch C, Leo A. Substituents constants for correlation analysis in chemistry and biology. John Wiley, New York 1979
  • Wold S. Quant Struct-Act Relat 1991; 10: 191–193

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.